12,701 Shares in Galecto, Inc. (NASDAQ:GLTO) Bought by Squarepoint Ops LLC

Squarepoint Ops LLC bought a new position in shares of Galecto, Inc. (NASDAQ:GLTO) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 12,701 shares of the company’s stock, valued at approximately $59,000. Squarepoint Ops LLC owned approximately 0.96% of Galecto at the end of the most recent quarter.

Galecto Trading Up 2.1%

Shares of GLTO stock opened at $3.36 on Wednesday. Galecto, Inc. has a 12 month low of $2.01 and a 12 month high of $16.07. The company has a market cap of $4.44 million, a P/E ratio of -0.18 and a beta of 1.32. The firm has a fifty day moving average price of $2.82 and a 200 day moving average price of $4.13.

Galecto (NASDAQ:GLTO) last released its quarterly earnings data on Thursday, May 8th. The company reported ($1.92) earnings per share (EPS) for the quarter. On average, equities analysts forecast that Galecto, Inc. will post -15.91 EPS for the current year.

Galecto Profile

Galecto, Inc, a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis.